Solve M.E. Vice President of Advocacy and Community Engagement Emily Taylor joins WYPR’s Midday host Tom Hall on Wednesday, December 15, from 12-1 pm ET / 9-10 am PT for a live radio conversation about our efforts to assist survivors with Long Covid and other post-infection chronic diseases. Also joining the conversation will be Long Covid Alliance […]
The FY22 Defense Appropriation provides funding to support therapeutic research related to medical threats, and treatments for Service Members in current and future battlefield settings. The managing agent for the funding opportunities is the Department of Defense Office of Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC). […]
The Global Interdependence Center, in partnership with the Solve Long Covid Initiative, is continuing our conference series exploring the pandemic’s long-term healthcare, policy, and economic impact, specifically the implications of long haul COVID or long COVID. Together, we invite you to join us for the signature event of this series, an in-person conference in New York City on Thursday, […]
Solve M.E. and The Biotechnology Innovation Organization (BIO) will co-host a three-hour virtual event “Long Covid: What Will It Take to Accelerate Therapeutic Progress?” on Tuesday, February 21 from 10:00 AM - 1:00 PM PT (1:00 - 4:00 PM ET). Our goal is to convene stakeholders to advance research and development to diagnose and treat […]
Advocacy Week 2023 will take place virtually and in person throughout the week of April 17th to April 22nd, 2023! Advocacy Week is a nationwide advocacy effort to connect people with ME/CFS, Long COVID, and associated conditions; scientists; clinicians, and caregivers to share their unique stories with Congress. Our ultimate goal is to make ME/CFS, […]
Join us for this month's Advocacy Cafe Chat! In this session, Solve's Vice President of Advocacy and Engagement Emily Taylor will review our recently updated Policy Advocacy Statement, which drives our decisions about the advocacy and engagement work we do here at Solve. Tune in to share your views about the updated Solve Policy Advocacy […]
Solve is a proud co-founder of the World ME Alliance and we invite you to join us this year for the World ME Day event Bridging Borders – Global Voices from the World ME Alliance! Solve M.E. President and CEO and World ME Alliance Co-Chair Emily Taylor will represent Solve as one of the many nonprofit […]
Orthostatic intolerance (OI) describes a group of circulatory disorders whose symptoms are characterized by a dramatic drop in blood flow to the brain when people are sitting for long periods or standing still. It is often associated with other acute issues, such as substantial drops in blood pressure, tachycardia, dizziness, fainting, or other long-term problems, […]
Please join us for the final, culminating webinar of the Infection-Associated Chronic Conditions Understanding and Engagement (ICUE) project, where we will discuss the findings and results from the project as well as on-going efforts to collaborate across the IACC community on advancing awareness, clinical care, patient support and research. During this webinar, you will hear […]
**NEW TIME AND DATE!** In 2021 the National Institutes of Health (NIH) launched the RECOVER Initiative, a patient-centered, integrated, adaptive research network created to study Long Covid. Included in the RECOVER Initiative infrastructure was the Commonalities with Other Post-Viral Syndromes Task Force. The Task Force included Solve President and CEO Emily Taylor, Dr. Leonard Jason […]
Dr. Akiko Iwasaki (Sterling Professor of Immunobiology and Molecular, Cellular and Developmental Biology at Yale University) is the first recipient of Solve’s ME/CFS Catalyst Award in support of her study, “Probing Functional Autoantibodies in Patients with ME/CFS.” In this webinar, Dr. Iwasaki will talk to Solve CEO Emily Taylor about the study, which focuses on […]
